Mitochondrial dysfunction promotes and aggravates the inflammatory response in normal human synoviocytes

Rheumatology (United Kingdom)

Volumn 53, Issue 7, 2014, Pages 1332-1343

  Valcárcel Ares, Marta N ^a   Riveiro Naveira, Romina R ^a   Vaamonde García, Carlos ^a   Loureiro, Jesús ^a   Hermida Carballo, Laura ^a   Blanco, Francisco J ^a   López Armada, María J ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Inflammation; Mitochondria; Oxidative stress; Resveratrol; Rheumatoid arthritis; Synoviocytes

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; ACETYLCYSTEINE; ANTIMYCIN A1; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; OLIGOMYCIN; PARAQUAT; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; RESVERATROL;

ADULT; ARTICLE; CYTOKINE PRODUCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

INFLAMMATION; MITOCHONDRIA; OXIDATIVE STRESS; RESVERATROL; RHEUMATOID ARTHRITIS; SYNOVIOCYTES;

AGED; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INHIBITORS; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; MIDDLE AGED; MITOCHONDRIA; NF-KAPPA B; OLIGOMYCINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; STILBENES; SYNOVIAL MEMBRANE;

EID: 84902963688     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu016     Document Type: Article

References (50)

1. Schett G, Firestein G. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis 2010; 69:787-9.
2. Müller-Ladner U, Ospelt C, Gay S, Distler O, Pap T. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. Arthritis Res Ther 2007; 9:223.
3. Filippin LI, Vercelino R, Marroni NP, Xavier RM. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 2008; 152:415-22.
4. Altindag O, Karakoc M, Kocyigit A, Celik H, Soran N. Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem 2007; 40:167-71.
5. Biniecka M, Kennedy A, Fearon U et al. Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis 2010; 69:1172-8.
6. Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002; 21:200-4.
7. Wruck CJ, Fragoulis A, Gurzynski A et al. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis 2011; 70:844-50.
8. Biniecka M, Kennedy A, Ng CT et al. Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther 2011;13: R121.
9. Henze K, Martin W. Evolutionary biology: essence of mitochondria. Nature 2003; 426:127-8.
10. Biniecka M, Fox E, Gao W et al. Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis. Arthritis Rheum 2011; 63:2172-82.
11. Maneiro E, Martín M, de Andres M et al. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum 2003; 48:700-8.
12. Ong S, Subrayan S, Lim S et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010; 121:2012-22.
13. Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2011; 8:92-103.
14. Vaamonde-García C, Riveiro-Naveira RR, Valcárcel-Ares MN et al. Mitochondrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes. Arthritis Rheum 2012; 64:2927-36.
15. Ishikawa S, Mima T, Aoki C et al. Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis. Ann Rheum Dis 2009;68: 264-72.
16. Cillero-Pastor B, Martin MA, Arenas J, López-Armada MJ, Blanco FJ. Effect of nitric oxide on mitochondrial activity of human synovial cells. BMC Musculoskelet Disord 2011; 12:42.
17. Largo R, Díez-Ortego I, Sanchez-Pernaute O et al. EP2/ EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts. Ann Rheum Dis 2004; 63:1197-204.
18. Cillero-Pastor B, Caramés B, Lires-Deán M et al. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Arthritis Rheum 2008; 58:2409-19.
19. Hao W, Chang CP, Tsao CC, Xu J. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J Biol Chem 2010;285: 12647-54.
20. Wright HL, Bucknall RC, Moots RJ, Edwards SW. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology 2012; 51:451-9.
21. Johnson K, Svensson C, Etten D et al. Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigs. Arthritis Rheum 2004; 50:1216-25.
22. Rego-Pérez I, Fernández-Moreno M, Deberg M et al. Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Ann Rheum Dis 2010; 69:910-7.
23. Moodley D, Mody G, Patel N, Chuturgoon AA. Mitochondrial depolarisation and oxidative stress in rheumatoid arthritis patients. Clin Biochem 2008;41: 1396-401.
24. Ruiz-Romero C, López-Armada MJ, Blanco FJ. Mitochondrial proteomic characterization of human normal articular chondrocytes. Osteoarthritis Cartilage 2006; 14:507-18.
25. Ospelt C, Gay S. Somatic mutations in mitochondria: the chicken or the egg? Arthritis Res Ther 2005;7:179-80.
26. Da Sylva T, Connor A, Mburu Y, Keystone E, Wu G. Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res Ther 2005;7:R844-51.
27. Harty LC, Biniecka M, O'Sullivan J et al. Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis. Ann Rheum Dis 2012; 71:582-8.
28. Collins L, Hajizadeh S, Holme E, Jonsson I, Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol 2004; 75:995-1000.
29. Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008; 7:567-73.
30. Kepp O, Galluzzi L, Kroemer G. Mitochondrial control of the NLRP3 inflammasome. Nat Immunol 2011;12: 199-200.
31. Zhang Q, Raoof M, Chen Y et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104-7.
32. López-Armada MJ, Sánchez-Pernaute O, Largo R et al. Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis. Ann Rheum Dis 2002;61: 1027-30.
33. Martel-Pelletier J, Pelletier J, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003; 33:155-67.
34. Crofford L, Tan B, McCarthy C, Hla T. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997; 40:226-36.
35. López-Armada MJ, Caramés B, Lires-Deán M et al. Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes. Osteoarthritis Cartilage 2006; 14:660-9.
36. Park J, Pillinger M, Abramson S. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 2006; 119:229-40.
37. Faour WH, He Y, He QW et al. Prostaglandin E regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J Biol Chem 2001; 276:31720-31.
38. Poli G, Biasi F, Leonarduzzi G. 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol Aspects Med 2008; 29:67-71.
39. Li X, Ellman M, Muddasani P et al. Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum 2009; 60:513-23.
40. Demasi M, Cleland LG, Cook-Johnson RJ, James MJ. Effects of hypoxia on the expression and activity of cyclooxygenase 2 in fibroblast-like synoviocytes: interactions with monocyte-derived soluble mediators. Arthritis Rheum 2004; 50:2441-9.
41. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993; 12:3095-104.
42. Aguilera-Aguirre L, Bacsi A, Saavedra-Molina A et al. Mitochondrial dysfunction increases allergic airway inflammation. J Immunol 2009; 183:5379-87.
43. Kriete A, Mayo KL. Atypical pathways of NF-kappaB activation and aging. Exp Gerontol 2009; 44:250-5.
44. Amma H, Naruse K, Ishiguro N, Sokabe M. Involvement of reactive oxygen species in cyclic stretch-induced NFkappaB activation in human fibroblast cells. Br J Pharmacol 2005; 145:364-73.
45. 2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 2007;H37-47.
46. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol 2011; 12:695-708.
47. Xuzhu G, Komai-Koma M, Leung BP et al. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 2012; 71:129-35.
48. Dave M, Attur M, Palmer G et al. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum 2008; 58:2786-97.
49. Park SJ, Ahmad F, Philp A et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012; 148:421-33.
50. Zhang Q, Pi J, Woods CG, Andersen ME. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol 2010; 244:84-97.